Vimarsana
Biggest News Aggregation in the World

Page 3 - Capitol Beat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Capitol Beat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Capitol Beat Today - Breaking & Trending Today

Tax incentives failed to boost music industry in Georgia - Vimarsana News

Tax incentives failed to boost music industry in Georgia

Fans of Georgia’s music industry entered this year’s legislative session hoping lawmakers would renew state tax incentives, but that never happened.

Push to grow Georgia music industry fizzles under Gold Dome - Vimarsana News

Push to grow Georgia music industry fizzles under Gold Dome

ATLANTA – Supporters of Georgia’s music industry entered this year’s General Assembly session optimistic lawmakers would renew state tax incentives to lure music producers and create a state office dedicated

Push to grow Georgia music industry fizzles under Gold Dome - Vimarsana News

Push to grow Georgia music industry fizzles under Gold Dome

ATLANTA – Supporters of Georgia’s music industry entered this year’s General Assembly session optimistic lawmakers would renew state tax incentives to lure music producers and create a state office dedicated

Kemp: Federal EV tax credits excluding Georgia manufacturers - Vimarsana News

Kemp: Federal EV tax credits excluding Georgia manufacturers

ATLANTA – Gov. Brian Kemp is resuming a push to increase the list of electric vehicle manufacturers that will qualify for federal tax credits under legislation Congress passed last year.

Prescription drug price reform bill fell apart in state Senate over small business concerns - Vimarsana News

Prescription drug price reform bill fell apart in state Senate over small business concerns

ATLANTA – After sailing through the Georgia House of Representatives, a close vote in a Senate committee blocked the progress of a bill aimed at reducing some prescription drug costs